Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks to Watch Today: QXO, ImmunityBio, PayPay, and More

Ten stocks kicked off the trading week delivering strong gains, mimicking a broader market optimism after the US announced a five-day halt in strikes on Iran.

Wall Street’s major indices all clocked in more than 1 percent gains, with the Nasdaq and the Dow Jones both leading the gains, up 1.38 percent. The S&P 500 also increased by 1.15 percent.

In this article, we focus on the 10 top performers on Monday and detail the reasons behind their gains.

To come up with the list, we focused on the stocks with a $2 billion market capitalization and 5 million shares in trading volume.

Photo by Tima Miroshnichenko on Pexels

10. QXO Inc. (NYSE:QXO)

Shares of QXO bounced back by 8.91 percent on Monday to finish at $20.30 apiece, as investors resorted to bargain-hunting after the stock fell to a nearly four-month low the day prior.

It can be recalled that QXO Inc. (NYSE:QXO) dropped to as low as $18.48 on Friday—a level it last touched on December 2, 2025, and which investors took as an opportunity to hunt for low prices on Monday.

The stock also mirrored an overall market optimism after President Donald Trump announced over the weekend that the US would halt striking Iran for five days to give way for negotiations.

In his post on Truth Social, Trump said that he had very good and productive conversations regarding a complete and total resolution of attacks in the Middle East and that he had instructed the Department of War “to postpone any and all military strikes against Iranian power plants and energy infrastructure for a five-day period, subject to the success of ongoing meetings and discussions.”

In other news, QXO Inc. (NYSE:QXO) recently welcomed Robert Loughran as its new interim Chief Accounting Officer (CAO) after Sean Smith stepped down from the position last March 15 to pursue employment closer to home.

Smith will remain in an advisory role until June 30 to facilitate an orderly transition.

9. WeRide Inc. (NASDAQ:WRD)

WeRide rallied for a second day on Monday, jumping 8.98 percent to close at $6.92 apiece, as investors cheered its strong earnings performance last year, having narrowed its losses and increased revenues by nearly 90 percent.

In an updated report, WeRide Inc. (NASDAQ:WRD) said that it narrowed its full-year 2025 net loss by 34.5 percent to 1.65 billion yuan from 2.52 billion yuan in 2024. Revenues, however, increased by 89 percent to 684 million yuan from 361 million yuan year-on-year, thanks to a 310-percent jump in product revenues at 359.8 million yuan from only 87.7 million yuan in the same comparable period.

Meanwhile, service revenues stood at 324.7 million yuan, or a 19 percent jump from 273.4 million yuan year-on-year.

In the fourth quarter alone, net loss shrank by 6 percent to 556 million yuan from 592 million yuan, while revenues soared by 123 percent to 313.99 million yuan from 140.8 million yuan year-on-year.

“Robotaxi remained a key driver of our operational growth during the reporting period, powered by continued commercialization in China and ongoing international deployment. During the period, we have advanced toward a more data-driven autonomy stack by incorporating end-to-end learning, leveraging large-scale data training and world model simulation, as well as improving algorithm generalization. As of the date of this announcement, our global robotaxi fleet size has reached the new height of 1,125 vehicles,” WeRide Inc. (NASDAQ:WRD) said.

In line with the strong results, WeRide Inc. (NASDAQ:WRD) announced that it would repurchase $100 million worth of its Class A ordinary shares over the next 12 months. The buyback could be implemented from time to time on the open market at prevailing market prices, as well as in private negotiations.

8. Compass Inc. (NYSE:COMP)

Compass saw its share prices jump by 9.01 percent on Monday to close at $8.47 apiece, as investors mirrored a broader market optimism, while cheering its resolution of a legal case with Zillow in relation to the latter’s marketing ban.

In a statement last week, Compass Inc. (NYSE:COMP) said that it officially withdrew its lawsuit against Zillow following the latter’s announcement that it will no longer ban homesellers and their real estate brokers from publicly marketing a listing on the Compass family of websites or Redfin.com before marketing on Zillow.

“The end of the ‘Zillow Ban’ is a major victory for homesellers and their real estate professionals. It ensures that homeowners have the freedom to decide when, where, and how to market their homes, and that real estate professionals can uphold their fiduciary duties to their clients without fear of being banned by Zillow,” Compass Inc. (NYSE:COMP) said.

“With homesellers and their real estate professionals no longer subject to punishment by Zillow for publicly marketing a home, Compass will voluntarily dismiss its lawsuit,” it added.

Compass Inc. (NYSE:COMP) is a global real estate services company with a presence in the US and 120 other countries. It serves millions of buyers and sellers through brands @properties, Better Homes and Gardens, Century 21, Compass, and Corcoran, among others.

7. Applied Optoelectronics Inc. (NASDAQ:AAOI)

Applied Optoelectronics bounced back by 9.39 percent on Monday to end at $95.76 apiece, as investors took heart from a new $53 million deal with one of its major customers for the supply of 800G single-mode data center transceivers for its AI workloads.

In a statement on the same day, Applied Optoelectronics Inc. (NASDAQ:AAOI) said that the amount marks the initial volume order from the said company, with more expected to come in line with its ongoing expansion program.

Shipments are expected to start in the second quarter of the year, with completion in the middle of the third quarter.

“AI infrastructure expansion is accelerating, and requires significantly higher bandwidth at scale,” Applied Optoelectronics Inc. (NASDAQ:AAOI) Chairman and CEO Thompson Lin said.

“Our customers are adopting 800G not just for capacity and performance, but to manage long-term operating costs. Deploying 800G now helps to prevent network bottlenecks, improves power efficiency and lowers cost per bit, reducing the need for frequent upgrades,” he noted.

Launched in September last year, the 800G optical transceivers are built for high-performance AI and cloud data center networks requiring superior port density and bandwidth efficiency. It is available in standard pluggable form factors and is essential for high-capacity spine switching and high-speed GPU cluster interconnects.

6. ImmunityBio Inc. (NASDAQ:IBRX)

ImmunityBio jumped by 10.98 percent on Monday to close at $9.40 apiece, as investors cheered its future expansion into Asia following the go-signal of the Macau special administrative region (SAR) for its bladder cancer treatment, Anktiva.

In a statement over the weekend, ImmunityBio Inc. (NASDAQ:IBRX) said that it officially secured the green light of Macau to market and sell Anktiva in the SAR, marking its first entry into Asia.

“This authorization marks an important step in establishing ANKTIVA in Asia and advancing our broader international expansion strategy,” ImmunityBio Inc. (NASDAQ:IBRX) President and CEO Richard Adcock said.

“We are engaging with additional health authorities across the Asia-Pacific region and, in parallel, beginning to prepare for potential commercial distribution, recognizing there is still meaningful work ahead as we pursue further regulatory authorizations. Our focus is on executing this expansion in a disciplined manner, building on our existing approvals to support long-term global access for patients,” he noted.

The recent approval followed earlier permissions from the United States, Europe, and Saudi Arabia to market and sell the same treatment in the said areas.

Last year, Anktiva propelled ImmunityBio Inc.’s (NASDAQ:IBRX) full-year 2025 revenues by 671 percent to $113 million from only $14.7 million in 2024, reflecting strong adoption for the treatment, with sales volume expanding by 750 percent.

While we acknowledge the potential of IBRX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IBRX and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the other 5 Stocks to Watch Today.

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!